RankAlpha logo
Back to Rankings

IMVT

ImmunovantC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
View Chart
Current thesis
The post-print bull case is that the market is willing to look through the widened loss because IMVT-1402 produced strong open-label D2T RA activity, no new safety signals, and enough cash to fund announced indications through a potential GD launch. Stifel was reported to reiterate Buy with a $49 target after the release, reinforcing that some analysts see the data as supporting a higher valuation.
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +6.0.
What can break
Batoclimab discontinuation leaves IMVT-1402 as the dominant strategic driver, increasing concentration risk.
Momentum
89
Value
41
Sentiment
39
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $37.00 · Bull $52.00 · Bear $18.00
Data freshness
Prices
As of 2026-07-22
Fundamentals
As of 2026-07-22 • Vendor: Data Vendor v1
Scores
As of 2026-07-22 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-23 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-22
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $47.53
Why
Momentum89 · Δ7d +6.0
Value41 · Δ7d -0.0
Sentiment39 · Δ7d -2.3
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
89
26% active weight
Current posture
7d trendFlat
Δ7d
+6.0
Δ21d
+4.3
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-0.1
Sentiment
39
34% active weight
Current posture
7d trendSoftening
Δ7d
-2.3
Δ21d
-4.1
Why this grade

Composite grade C. Momentum 89.3 / Value 41.1 / Sentiment 38.9

Fundamentals (TTM)
As of 2026-07-22
Market Cap
$8.02B
Beta
0.54
Shares Out
205.31M
P/E (TTM) · Derived
-14.1
P/S (TTM)
-
P/FCF (TTM) · Derived
-17.33
Rev YoY
-
EPS YoY
+13.7%
Gross Margin
-
Op Margin
-
Net Debt
-$902.04M
Current Ratio
9.09
As of 2026-07-22 • Updated nightlySource: Internal modelMethodology